Management of Clozapine-Associated Constipation

Prevention Strategy

Prophylactic laxatives should be prescribed for all patients taking clozapine due to its high risk of causing severe constipation that can progress to life-threatening complications such as bowel obstruction, according to the National Comprehensive Cancer Network 1
Stimulant laxative (such as senna or bisacodyl) as prophylactic treatment is recommended 1, 2
Polyethylene glycol (PEG): 17g (heaping tablespoon) with 8 oz water twice daily is a recommended preventive measure 2
Increase fluid intake and encourage physical activity when appropriate, as suggested by the National Comprehensive Cancer Network 3, 4
Dietary interventions with adequate fiber intake for patients with sufficient fluid intake are recommended 3, 4

Aim for one non-forced bowel movement every 1-2 days, according to the National Comprehensive Cancer Network 3, 4
Titrate stimulant laxatives: bisacodyl 10-15 mg daily to TID, as recommended by the National Comprehensive Cancer Network 5, 3
Ensure adequate hydration and physical activity if appropriate 5, 3
Add osmotic laxatives such as polyethylene glycol (1 capful/8 oz water BID) for persistent constipation 5, 3
Consider adding a prokinetic agent (e.g., metoclopramide 10-20 mg PO QID) for severe or refractory cases 5, 3
Peripherally acting μ-opioid receptor antagonists like methylnaltrexone (0.15 mg/kg subcutaneously every other day) may be considered for severe constipation 3, 4

Failing to provide prophylactic treatment from the start of clozapine therapy can lead to severe complications, as noted by Genetics in Medicine 1
Using stool softeners alone without stimulant laxatives is not recommended, according to the Journal of the National Comprehensive Cancer Network 2

The National Comprehensive Cancer Network (NCCN) recommends against using docusate (stool softener) alone or as primary therapy for clozapine-induced constipation, as it has no proven benefit 6
The NCCN also advises against adding psyllium or fiber supplements for clozapine-induced constipation, as they are ineffective and may worsen symptoms 6

The NCCN suggests ruling out bowel obstruction if constipation worsens despite treatment 6

The American Society of Clinical Oncology recommends avoiding fiber supplements or psyllium as they can worsen obstruction in patients with reduced gastrointestinal motility 7

The National Comprehensive Cancer Network recommends considering abdominal examination and digital rectal exam if constipation is suspected 8

The National Comprehensive Cancer Network recommends increasing bisacodyl to 10-15 mg two to three times daily to optimize first-line laxatives 9
The American Society of Clinical Oncology recommends increasing fluid intake significantly and encouraging physical activity within patient's limitations to optimize first-line laxatives 7

The National Comprehensive Cancer Network recommends using glycerin suppository as first-line rectal intervention for fecal impaction 9
The American Society of Clinical Oncology recommends manual disimpaction with premedication with analgesic ± anxiolytic before performing digital fragmentation and extraction 7

The American Society of Clinical Oncology recommends ruling out bowel obstruction with physical exam and considering abdominal x-ray if symptoms worsen despite treatment 9

The American Society of Clinical Oncology recommends immediately evaluating for surgical emergency if patient develops severe abdominal pain 7
The European Society of Gastrointestinal Endoscopy recommends immediately evaluating for surgical emergency if patient develops abdominal distension with absent bowel sounds 10

The American Society of Clinical Oncology recommends ensuring privacy and proper positioning for defecation and using abdominal massage to provide additional benefit 7 8